Epilepsy Diagnosis & Treatment Market Research Report Information By Type (Idiopathic, Cryptogenic and Symptomatic), By Diagnosis (Neurological Exam, Blood Test and Imaging), By Treatment (Medication and Surgery) By End-User (Hospitals and Clinics) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Epilepsy Diagnosis and Treatment Market, by Type

6.1 Introduction

6.2 Idiopathic

Market Estimates & Forecast, 2023-2032

6.3 Cryptogenic

Market Estimates & Forecast, 2023-2032

6.4 Symptomatic

Market Estimates & Forecast, 2023-2032

6.5 Others

Chapter 7. Global Epilepsy Diagnosis and Treatment Market, by Diagnosis

7.1 Introduction

7.2 Neurological Exam

Market Estimates & Forecast, 2023-2032

7.3 Blood Test

Market Estimates & Forecast, 2023-2032

7.4 Imaging

Market Estimates & Forecast, 2023-2032

7.4.1 Electroencephalogram

7.4.2 Computerized Tomography

7.4.3 Magnetic Resonance Imaging

7.4.4 Positron Emission Tomography

7.4.5 Others

Chapter 8. Global Epilepsy Diagnosis and Treatment Market, by Treatment

8.1 Introduction

8.2 Medication

Market Estimates & Forecast, 2023-2032

8.2.1 Acetazolamide

8.2.2 Carbamazepine

8.2.3 Clobazam

8.2.4 Others

8.3 Surgery

Market Estimates & Forecast, 2023-2032

8.3.1 Hemispherectomy

8.3.2 Corpus callosotomy

8.3.3 Resection Surgery

Market Estimates & Forecast, 2023-2032

8.3.3.1 Temporal Lobectomy

8.3.3.2 Lesionectomy

8.3.3.3 Others

8.4 Brain Stimulation

Market Estimates & Forecast, 2023-2032

8.4.1 Deep brain stimulation

8.4.2 Responsive neurostimulation

8.4.3 Others

8.5 Others

Chapter 9. Global Epilepsy Diagnosis and Treatment Market, by End User

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, 2023-2032

9.3 Diagnostic Centers

Market Estimates & Forecast, 2023-2032

9.4 Others

Chapter 10. Global Epilepsy Diagnosis and Treatment Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Pfizer, Inc.

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 Johnson & Johnson Services, Inc.

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 UCB Pharma Ltd.

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Abbott

12.4.1 Company Overview

12.4.2 Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 GlaxoSmithKline plc

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Novartis International AG

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Sanofi S.A.

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Shire

12.8.1 Overview

12.8.2 Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Medtronic

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 NeuroWave Systems Inc.

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Natus Medical Incorporated.

12.11.1 Overview

12.11.2 Type Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Siemens Ltd.

12.12.1 Overview

12.12.2 Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Epilepsy Diagnosis and Treatment Market

Chapter 14 Appendix

LIST OF TABLES

Table 1 Epilepsy Diagnosis and Treatment Industry Synopsis, 2023-2032

Table 2 Global Epilepsy Diagnosis and Treatment Market Estimates and Forecast, 2023-2032, (USD Million)

Table 3 Global Epilepsy Diagnosis and Treatment Market by Region, 2023-2032, (USD Million)

Table 4 Global Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 5 Global Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 6 Global Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 7 Global Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 8 North Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 9 North Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 10 North Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 11 North Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 12 U.S. Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 13 U.S. Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 14 U.S. Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 15 U.S. Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 16 Canada Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 17 Canada Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 18 Canada Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 19 Canada Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 20 South America Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 21 South America Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 22 South America Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 23 South America Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 24 Europe Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 25 Europe Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 26 Europe Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 27 Europe Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 28 Western Europe Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 29 Western Europe Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 30 Western Europe Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 31 Western Europe Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 32 Eastern Europe Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 33 Eastern Europe Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 34 Eastern Europe Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 35 Eastern Europe Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 36 Asia Pacific Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 37 Asia Pacific Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 38 Asia Pacific Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 39 Asia Pacific Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

Table 40 The Middle East & Africa Epilepsy Diagnosis and Treatment Market by Type, 2023-2032, (USD Million)

Table 41 The Middle East & Africa Epilepsy Diagnosis and Treatment Market by Diagnosis, 2023-2032, (USD Million)

Table 42 The Middle East & Africa Epilepsy Diagnosis and Treatment Market by Treatment, 2023-2032, (USD Million)

Table 43 The Middle East & Africa Epilepsy Diagnosis and Treatment Market by End User, 2023-2032, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Epilepsy Diagnosis and Treatment Market

Figure 3 Market Dynamics for Global Epilepsy Diagnosis and Treatment Market

Figure 4 Global Epilepsy Diagnosis and Treatment Market Share, by Type 2020

Figure 5 Global Epilepsy Diagnosis and Treatment Market Share, by Diagnosis 2020

Figure 6 Global Epilepsy Diagnosis and Treatment Market Share, by Treatment, 2020

Figure 7 Global Epilepsy Diagnosis and Treatment Market Share, by End User, 2020

Figure 8 Global Epilepsy Diagnosis and Treatment Market Share, by Region, 2020

Figure 9 North Epilepsy Diagnosis and Treatment Market Share, by Country, 2020

Figure 10 Europe Epilepsy Diagnosis and Treatment Market Share, by Country, 2020

Figure 11 Asia Pacific Epilepsy Diagnosis and Treatment Market Share, by Country, 2020

Figure 12 The Middle East & Africa Epilepsy Diagnosis and Treatment Market Share, by Country, 2020

Figure 13 Global Epilepsy Diagnosis and Treatment Market: Company Share Analysis, 2020 (%)

Figure 14 Pfizer, Inc. : Key Financials

Figure 15 Pfizer, Inc. : Segmental Revenue

Figure 16 Pfizer, Inc. : Geographical Revenue

Figure 17 Johnson & Johnson Services, Inc.: Key Financials

Figure 18 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 19 Johnson & Johnson Services, Inc.: Geographical Revenue

Figure 20 UCB Pharma Ltd.: Key Financials

Figure 21 UCB Pharma Ltd.: Segmental Revenue

Figure 22 UCB Pharma Ltd.: Geographical Revenue

Figure 23 Abbott: Key Financials

Figure 24 Abbott: Segmental Revenue

Figure 25 Abbott: Geographical Revenue

Figure 26 GlaxoSmithKline plc: Key Financials

Figure 27 GlaxoSmithKline plc: Segmental Revenue

Figure 28 GlaxoSmithKline plc: Geographical Revenue

Figure 29 Novartis International AG: Key Financials

Figure 30 Novartis International AG: Segmental Revenue

Figure 31 Novartis International AG: Geographical Revenue

Figure 32 Sanofi S.A.: Key Financials

Figure 33 Sanofi S.A.: Segmental Revenue

Figure 34 Sanofi S.A.: Geographical Revenue

Figure 35 Shire: Key Financials

Figure 36 Shire: Segmental Revenue

Figure 37 Shire: Geographical Revenue

Figure 38 Medtronic: Key Financials

Figure 39 Medtronic: Segmental Revenue

Figure 40 Medtronic: Geographical Revenue

Figure 41 NeuroWave Systems Inc.: Key Financials

Figure 42 NeuroWave Systems Inc.: Segmental Revenue

Figure 43 NeuroWave Systems Inc.: Geographical Revenue

Figure 44 Natus Medical Incorporated.: Key Financials

Figure 45 Natus Medical Incorporated.: Segmental Revenue

Figure 46 Natus Medical Incorporated.: Geographical Revenue

Figure 47 Siemens Ltd.: Key Financials

Figure 48 Siemens Ltd.: Segmental Revenue

Figure 49 Siemens Ltd.: Geographical Revenue